Valora Therapeutics Inc.
PrivateLast Round
Seed
Nov 20, 2024
Total Funding Raised
$30M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Valora Therapeutics Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Seed round in November 2024.
Valora Therapeutics Inc. is a biotechnology company that develops novel biotherapeutic drug candidates for oncology and immune diseases using its proprietary AbLec glyco-immune checkpoint modulation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valora Therapeutics Inc. Comparables
Compare Valora Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GO Therapeutics | 83% | |
| Palleon Pharmaceuticals | 82% | |
| GlycoTherapeutics | 80% |
For institutional investors. Book with your work email.
Valora Therapeutics Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Valora Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alexandria Venture Investments | Seed |
| Avalon BioVentures | Seed |
| Correlation Ventures | Seed |
| TigerGene | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 45% MoM.
- Jun 18, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Valora Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Valora Therapeutics Inc.'s valuation, stock price, and market status.
Is Valora Therapeutics Inc. a public or private company?
Valora Therapeutics Inc. is a private company.
What is the current stock price of Valora Therapeutics Inc.?
Valora Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Valora Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Valora Therapeutics Inc. worth (valuation)?
Valuation information for Valora Therapeutics Inc. is not publicly available.
Can I buy Valora Therapeutics Inc. stock?
Valora Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Valora Therapeutics Inc.'s last funding round?
Valora Therapeutics Inc.'s most recent funding round was Seed on November 20, 2024.
Who are the main investors in Valora Therapeutics Inc.?
Key investors in Valora Therapeutics Inc. include Avalon BioVentures, TigerGene.
Will Valora Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Valora Therapeutics Inc..
How can I track Valora Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Valora Therapeutics Inc.'s shares on secondary markets.